Developer of minimally invasive, multi-molecule biosensors for continuous health monitoring. The biosensors gather data from just beneath the skin, providing real-time insights into various molecules. This technology enables continuous monitoring of health parameters, transitioning from episodic testing to continuous data streams accessible via a connected platform. Sava operates in the Disease Self Management, Healthcare IT, Wearable Technology sectors. The company focuses on Remote Patient Monitoring, Devices, Impl. The company has raised $38.5M in Series A funding. Notable investors include Balderton Capital, Exor, Pentland Ventures, Norrsken VC, JamJar Investments, True Global, among others. Sava was founded in 2021 and is headquartered in London, United Kingdom.
Sava
Series ADeveloper of minimally invasive, multi-molecule biosensors for continuous health monitoring. The biosensors gather data from just beneath the skin, providing real-time insights into various molecules. This technology enables continuous monitoring of health parameters, transitioning from episodic testing to continuous data streams accessible via a connected platform. Sava operates in the Disease Self Management,…
About
Business model
Wearable Technology > Health and Wellness Devices > Remote Patient Monitoring,
Disease Self Management > Diversified > Devices,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Implantable > Diabetes
Founders & team highlights
Serial Founder
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Explore HealthTech investors — funds that write checks in this sector.